Scientists develop a marker for therapy response in acute myeloid leukemia


With the combination of the drugs Venetoclax and 5-Azacitidine, a new, effective and more tolerable alternative to chemotherapy for the treatment of AML has been available for several years. But for some patients, the drug combination does not work.

Researchers find new way to remove waste after brain hemorrhage

Previous article

Study demonstrates effectiveness of a procedure done under the skin to treat uncontrolled hypertension

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News